At low doses, CA-4 stabilizes tumor vasculature and promotes immune infiltration (He et al, 2025), while at higher doses, it disrupts the vasculature, causing vessel collapse, hemorrhage, and tumor necrosis (Taguchi et al, 2021). This evidence concerns the gene CA4 and neoplasm.